170 related articles for article (PubMed ID: 35346577)
1. Impact of Fuzheng Huayu tablet on antiviral effect of entecavir in patients with hepatitis B cirrhosis.
Cheng DY; Zhao ZM; Wan G; Zheng HW; Huang JQ; Liu CH; Xing HC
Hepatobiliary Pancreat Dis Int; 2022 Oct; 21(5):479-484. PubMed ID: 35346577
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of Fuzheng Huayu tablet on persistent advanced liver fibrosis following 2 years entecavir treatment: A single arm clinical objective performance criteria trial.
Zhao ZM; Zhu CW; Huang JQ; Li XD; Zhang YX; Liang J; Zhang W; Zhang Y; Jiang XG; Zong YL; Zhang KJ; Sun KW; Zhang B; Lv YH; Xing HC; Xie Q; Liu P; Liu CH
J Ethnopharmacol; 2022 Nov; 298():115599. PubMed ID: 35932973
[TBL] [Abstract][Full Text] [Related]
3. Safety and therapeutic effects of anti-fibrotic Traditional Chinese Medicine Fuzheng Huayu on persistent advanced stage fibrosis following 2 years entecavir treatment: Study protocol for a single arm clinical objective performance criteria trial.
Chen Y; Zhao Z; Fan H; Li Z; He Y; Liu C
Contemp Clin Trials Commun; 2020 Sep; 19():100601. PubMed ID: 32642592
[TBL] [Abstract][Full Text] [Related]
4. Treatment of HBV Cirrhosis with Fuzheng Huayu Tablet () and Entecavir: Design of a Randomized, Double-Blind, Parallel and Multicenter Clinical Trial.
Li ZX; Zhao ZM; Liu P; Zheng QS; Liu CH
Chin J Integr Med; 2021 Jul; 27(7):509-513. PubMed ID: 32572776
[TBL] [Abstract][Full Text] [Related]
5. Relationship between virological response and FIB-4 index in chronic hepatitis B patients with entecavir therapy.
Li N; Xu JH; Yu M; Wang S; Si CW; Yu YY
World J Gastroenterol; 2015 Nov; 21(43):12421-9. PubMed ID: 26604649
[TBL] [Abstract][Full Text] [Related]
6. [Clinical study of yiqi huoxue recipe in the treatment of liver fibrosis of chronic viral hepatitis].
Cui LY; Zhang XX; Cui P; Li WC; Zhang YG; Wang RQ; Zhao SX; Ren WG; Kong LL; Han F; Yuan XW; Liu LD; Zhang Y; Zhang QS; Kong L; Nan YM
Zhonghua Gan Zang Bing Za Zhi; 2020 May; 28(5):403-409. PubMed ID: 32536056
[No Abstract] [Full Text] [Related]
7. [Entecavir combined with Fufang Biejia Ruangan tablet in treatment of chronic hepatitis B patients with liver fibrosis: 96-week efficacy analyses].
Yang NH; Yuan GS; Zhou YC; Liu JW; Huang HP; Hu CG; Xiong L; Li Y; Zhou FY; Yang SL; Zhou YP
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jun; 36(6):775-9. PubMed ID: 27320877
[TBL] [Abstract][Full Text] [Related]
8. [Fuzheng Huayu capsules reducing development of hepatocellular carcinoma in cirrhotic patients with chronic hepatitis B based on the ratio of neutrophils/lymphocytes].
Shi K; Hou J; Zhang Y; Bi YF; Wang XB
Zhonghua Gan Zang Bing Za Zhi; 2023 Sep; 31(9):969-973. PubMed ID: 37872093
[No Abstract] [Full Text] [Related]
9. Evaluation of the efficacy of Biejia decoction pill combined with entecavir in the treatment of hepatitis B liver fibrosis/cirrhosis by VCTE.
Wan L; Hu C; Wang F; Xu K; Li F; He B; Wu Z; Luo L; Wen Z
Sci Rep; 2023 Nov; 13(1):19616. PubMed ID: 37949927
[TBL] [Abstract][Full Text] [Related]
10. Baseline Hepatitis B Virus DNA Level is a Promising Factor for Predicting the 3 (rd) Month Virological Response to Entecavir Therapy: A Study of Strict Defined Hepatitis B virus Induced Cirrhosis.
Xu Y; Wu XN; Shi YW; Wei W; Yang AT; Sun YM; Zhao WS; You H
Chin Med J (Engl); 2015 Jul; 128(14):1867-72. PubMed ID: 26168824
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of YinQiSanHuang-antiviral decoction in chronic hepatitis B: study protocol for a randomized, placebo-controlled, double-blinded trial.
Wu QJ; Lv WL; Li JM; Zhang TT; Zhou WH; Zhang Q; Wang JC; Wang QN; Zhang RX; Zhao X; Chen ST; Liu S; Li GH; Cao ZM; Xu L; Chen J
Trials; 2020 Jun; 21(1):482. PubMed ID: 32503608
[TBL] [Abstract][Full Text] [Related]
12. Blocking and reversing hepatic fibrosis in patients with chronic hepatitis B treated by traditional Chinese medicine (tablets of biejia ruangan or RGT): study protocol for a randomized controlled trial.
Qu J; Yu Z; Li Q; Chen Y; Xiang D; Tan L; Lei C; Bai W; Li H; Shang Q; Chen L; Hu X; Lu W; Li Z; Chen D; Wang X; Zhang C; Xiao G; Qi X; Chen J; Zhou L; Chen G; Li Y; Zeng Z; Rong G; Dong Z; Chen Y; Lou M; Wang C; Lu Y; Zhang C; Yang Y
Trials; 2014 Nov; 15():438. PubMed ID: 25381721
[TBL] [Abstract][Full Text] [Related]
13. [Multicenter clinical study about the action of Fuzheng Huayu Capsule against liver fibrosis with chronic hepatitis B].
Liu P; Hu YY; Liu C; Xu LM; Liu CH; Sun KW; Hu DC; Yin YK; Zhou XQ; Wan MB; Cai X; Zhang ZQ; Ye J; Tang BZ; He J
Zhong Xi Yi Jie He Xue Bao; 2003 Jul; 1(2):89-98, 102. PubMed ID: 15339577
[TBL] [Abstract][Full Text] [Related]
14. [Effect of Fuzheng Huayu capsules on survival rate of patients with liver cirrhosis].
Ge XJ; Zhao CQ; Xu LM
Zhonghua Gan Zang Bing Za Zhi; 2017 Nov; 25(11):834-840. PubMed ID: 29325277
[No Abstract] [Full Text] [Related]
15. Efficacy and safety of entecavir in clinical practice in treatment-naive Caucasian chronic hepatitis B patients.
Buti M; Morillas RM; Prieto M; Diago M; Pérez J; Solà R; Bonet L; Palau A; Testillano M; García-Samaniego J; Rodríguez M;
Eur J Gastroenterol Hepatol; 2012 May; 24(5):535-42. PubMed ID: 22382708
[TBL] [Abstract][Full Text] [Related]
16. Cirrhosis has no impact on therapeutic responses of entecavir for chronic hepatitis B.
Wang PC; Wei TY; Tseng TC; Lin HH; Wang CC
Eur J Gastroenterol Hepatol; 2017 Aug; 29(8):946-950. PubMed ID: 28538267
[TBL] [Abstract][Full Text] [Related]
17. Effects of entecavir and lamivudine for hepatitis B decompensated cirrhosis: meta-analysis.
Ye XG; Su QM
World J Gastroenterol; 2013 Oct; 19(39):6665-78. PubMed ID: 24151397
[TBL] [Abstract][Full Text] [Related]
18. Entecavir Combined With Adefovir Ameliorates Patients With Chronic Hepatitis B Who Fail to Respond to Nucleotide (Acid) Analog Monotherapy.
Li XY; You X; Jie YS; Lin GL; Wu YK; Huang MX; Zhang M; Li ZY; Xie DY; Gao ZL; Chong YT
Am J Ther; 2017 May; 24(3):e250-e258. PubMed ID: 25923228
[TBL] [Abstract][Full Text] [Related]
19. A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients.
Zheng MH; Shi KQ; Dai ZJ; Ye C; Chen YP
Clin Ther; 2010 Apr; 32(4):649-58. PubMed ID: 20435234
[TBL] [Abstract][Full Text] [Related]
20. [Exploring the effects of entecavir treatment on the degree of liver fibrosis in patients with non-alcoholic fatty liver combined with chronic hepatitis B in Tibet region].
Wen QP; Qian H; Ba S; Lu MJ; Silang LDJ; Shi L
Zhonghua Gan Zang Bing Za Zhi; 2022 Mar; 30(3):304-308. PubMed ID: 35462487
[No Abstract] [Full Text] [Related]
[Next] [New Search]
